DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-376 Cr | ₹-2,686 Cr | ₹-242 Cr | ₹-30 Cr | ₹-2,516 Cr |
What is the latest Cash Flow from Financing Activities ratio of DR REDDYS LABORATORIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-376 Cr |
Mar2023 | ₹-2,686 Cr |
Mar2022 | ₹-242 Cr |
Mar2021 | ₹-30 Cr |
Mar2020 | ₹-2,516 Cr |
How is Cash Flow from Financing Activities of DR REDDYS LABORATORIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-376 Cr | Negative | |
Mar2023 | ₹-2,686 Cr | Negative | |
Mar2022 | ₹-242 Cr | Negative | |
Mar2021 | ₹-30 Cr | Negative | |
Mar2020 | ₹-2,516 Cr | - |
Compare Cash Flow from Financing Activities of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹110,701.3 Cr | -2.6% | 8.3% | 7.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,254.0 Cr | -2.5% | -4.9% | 8.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,374.0 Cr | -2.7% | -0.9% | 42.5% | Stock Analytics | |
CIPLA | ₹119,795.0 Cr | -1.5% | 0.1% | -4.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,218.0 Cr | -2.6% | -3.7% | 11.9% | Stock Analytics | |
MANKIND PHARMA | ₹95,866.6 Cr | -2.5% | -8.3% | 5.2% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -2.6% |
8.3% |
7.9% |
SENSEX | -0.4% |
0.2% |
5.9% |
You may also like the below Video Courses